ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...
The expert in complement therapeutics development, Creative Biolabs, keys the importance of complement function and activity tests in complement defect screening and drug development. The complement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback